Pendulum Therapeutics Overview
- Founded
- 2012

- Status
- Private
- Employees
- 78

- Latest Deal Type
- Series C
- Latest Deal Amount
- $55M

- Investors
- 15
Pendulum Therapeutics General Information
Description
Developer of microbiome interventions and drugs designed to improve healthcare by managing chronic illnesses and tackle type 2 diabetes. The company integrates laboratory science and computational analysis to gain a comprehensive view of each individual's microbiome through targeted probiotics and prebiotics and has developed drugs for the dietary management of type 2 diabetes, thus enabling clinicians to identify specific microbiome markers and interventions to treat diseases.
Contact Information
- 933 20th Street
- San Francisco, CA 94107
- United States
Pendulum Therapeutics Timeline
Pendulum Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC (Series C) | 01-Apr-2021 | $55M | 00000 | 00000 | Completed | Generating Revenue |
8. Later Stage VC (Series B) | 30-May-2019 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
7. Early Stage VC (Series A2) | 08-Jun-2017 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
6. Early Stage VC (Series A) | 26-Jan-2016 | 000 | 0000 | 0000 | Completed | Startup |
5. Grant | 01-Jan-2016 | 00000 | 000 | Completed | Startup | |
4. Seed Round | 15-Dec-2014 | 000 | 000 | 000.00 | Completed | Startup |
3. Accelerator/Incubator | 18-Jun-2014 | Completed | Startup | |||
2. Accelerator/Incubator | 13-Oct-2013 | Completed | Startup | |||
1. Accelerator/Incubator | Completed | Startup |
Pendulum Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series B | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Series A-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A | 11,797,144 | $0.000100 | $0.05 | $0.68 | $0.68 | 1x | $0.68 | 12.97% |
Seed | 5,785,203 | $0.000100 | $0.05 | $0.64 | $0.64 | 1x | $0.64 | 6.36% |
Pendulum Therapeutics Comparisons
Industry
0000 000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialPendulum Therapeutics Competitors (22)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Xeno Biosciences | Venture Capital-Backed | Somerville, MA | 0 | 00.00 | 00000000000 | 00.00 |
000000000 | Venture Capital-Backed | Research Triangle Park, NC | 000 | 00000 | 00000000000 | 00000 |
00000000 | Formerly VC-backed | Roseville, MN | 00 | 000.00 | 000000&0 | 000.00 |
00000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
0000000 000000000 | Venture Capital-Backed | Madison, WI | 00 | 000.00 | 000000000 - | 000.00 |
Pendulum Therapeutics Patents
Pendulum Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3137104-A1 | Microbial compositions and methods for greater tolerability and prolonged shelf life | Pending | 22-Apr-2019 | 0000000000 | |
AU-2020261345-A1 | Microbial compositions and methods for greater tolerability and prolonged shelf life | Pending | 22-Apr-2019 | 0000000000 | |
US-20210213078-A1 | Microbial compositions and methods of use | Pending | 24-Sep-2018 | 0000000000 | |
CA-3113684-A1 | Microbial compositions and methods of use | Pending | 24-Sep-2018 | 0000000000 | |
EP-3856214-A1 | Microbial compositions and methods of use | Pending | 24-Sep-2018 | A61K31/155 |
Pendulum Therapeutics Executive Team (8)
Pendulum Therapeutics Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Adam D'Augelli | True Ventures | Board Member | 000 0000 |
Colleen Cutcliffe Ph.D | Pendulum Therapeutics | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Craig Sherman | Meritech Capital Partners | Board Member | 000 0000 |
Heather Mason | Pendulum Therapeutics | Board Member | 000 0000 |
Hugh Martin | Self | Chairman | 000 0000 |
Pendulum Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPendulum Therapeutics Investors (15)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Meritech Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Mayo Clinic Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
SK Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Felicis Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Khosla Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |